Loading...

ConvaTec Group Plc

CNVVYPNK
Healthcare
Medical - Instruments & Supplies
$12.30
$-0.07(-0.57%)

ConvaTec Group Plc (CNVVY) Financial Performance & Income Statement Overview

View comprehensive annual and quarterly summaries for ConvaTec Group Plc (CNVVY), featuring income statements, balance sheets, and cash flow data.

Revenue Growth
6.85%
6.85%
Operating Income Growth
23.68%
23.68%
Net Income Growth
46.20%
46.20%
Operating Cash Flow Growth
7.84%
7.84%
Operating Margin
14.55%
14.55%
Gross Margin
55.17%
55.17%
Net Profit Margin
7.85%
7.85%
ROE
15.74%
15.74%
ROIC
16.27%
16.27%

ConvaTec Group Plc (CNVVY) Income Statement & Financial Overview

Explore comprehensive income reports for ConvaTec Group Plc CNVVY, broken down by year and quarter.

MetricQ4 2024Q2 2024Q4 2023Q3 2023
Revenue$1.18B$1.11B$1.08B$543.45M
Cost of Revenue$516.40M$489.20M$491.56M$239.40M
Gross Profit$659.40M$624.20M$586.70M$304.05M
Gross Profit Ratio$0.56$0.56$0.54$0.56
R&D Expenses$57.70M$54.00M$55.95M$28.40M
SG&A Expenses$422.60M$417.60M$376.58M$201.70M
Operating Expenses$483.70M$475.00M$432.54M$241.25M
Total Costs & Expenses$1.000B$964.20M$924.10M$480.65M
Interest Income$4.80M$0.00$2.98M$17.10M
Interest Expense$73.50M$0.00$32.74M$0.00
Depreciation & Amortization$122.50M$98.30M$107.84M$45.05M
EBITDA$289.30M$250.90M$231.25M$117.75M
EBITDA Ratio$0.25$0.23$0.24$0.22
Operating Income$175.70M$149.20M$154.17M$72.70M
Operating Income Ratio$0.15$0.13$0.14$0.13
Other Income/Expenses (Net)-$33.80M-$45.20M-$63.49M-$23.95M
Income Before Tax$141.90M$104.00M$90.67M$45.70M
Income Before Tax Ratio$0.12$0.09$0.08$0.08
Income Tax Expense$30.60M$25.40M$16.67M$8.40M
Net Income$111.90M$78.60M$74.007M$37.30M
Net Income Ratio$0.10$0.07$0.07$0.07
EPS$0.05$0.04$0.15$0.02
Diluted EPS$0.05$0.04$0.14$0.02
Weighted Avg Shares Outstanding$2.05B$2.06B$510.10M$2.07B
Weighted Avg Shares Outstanding (Diluted)$2.06B$2.06B$513.63M$2.06B

Over the last four quarters, ConvaTec Group Plc's revenue moved from $543.45M in Q3 2023 to $1.18B in Q4 2024. Operating income in Q4 2024 was $175.70M, with a strong operating margin of 15%. Despite fluctuations in R&D and SG&A expenses, EBITDA for ConvaTec Group Plc remained robust at $289.30M, reflecting operational efficiency. Net income rose to $111.90M, with an EPS of $0.05. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;